APA (7th ed.) Citation

Kotyla, P. J. (2018). Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients? BioMed Research International, 2018, 1. https://doi.org/10.1155/2018/7492904

Chicago Style (17th ed.) Citation

Kotyla, Przemyslaw J. "Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?" BioMed Research International 2018 (2018): 1. https://doi.org/10.1155/2018/7492904.

MLA (9th ed.) Citation

Kotyla, Przemyslaw J. "Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?" BioMed Research International, vol. 2018, 2018, p. 1, https://doi.org/10.1155/2018/7492904.